Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia

NCT00265915 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: rituximab
BIOLOGICAL: sargramostim

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]